Suppr超能文献

内皮素-1诱导人脑毛细血管内皮细胞产生的前列腺素概况。

Profile of prostaglandins induced by endothelin-1 in human brain capillary endothelium.

作者信息

Stanimirovic D B, Bacic F, Uematsu S, Spatz M

机构信息

Stroke Branch, NINDS, NIH, Bethesda, MD 20892.

出版信息

Neurochem Int. 1993 Oct;23(4):385-93. doi: 10.1016/0197-0186(93)90082-g.

Abstract

The vasoactive peptide, endothelin-1 (ET-1) has been implicated in the pathophysiology of various diseases. Recently, we have shown that human brain endothelial cells both secrete and express immunoreactive ET-1 high-affinity ETA receptors coupled to activation of phospholipase C (PLC). The present study demonstrates concentration-dependent stimulation of prostanoids [thromboxane B2 (TxB2), prostaglandin F2 alpha (PGF2 alpha), 6-keto prostaglandin F1 alpha (6-keto PGF1 alpha) prostaglandin E2 (PGE2), and prostaglandin D2 (PGD2)] production by ET-1 in capillary endothelial cells derived from human brain (HBCEC). The increase in the vasoconstrictive prostanoids TxA2 and PGF2 alpha temporally preceded that of the vasodilatory PGI2, PGE2 and PGD2, and was seen after 15 min of incubation with ET-1 (10 nM). Increased production of vasodilatory prostanoids was observed between 4-8 h of incubation, whereas normalization of both vasoconstrictive and vasodilatory prostaglandins occurred 24 h after addition of ET-1. Both ET-1-stimulated prostanoid and IP3 production were inhibited by BQ123, a specific antagonist of ETA receptors. ET-1-induced prostanoid secretion by HBCEC was also inhibited by dexamethasone (50 microM) and diminished by neomycin (50 microM) and verapamil (10 microM) but not by nifedipine. Phorbol myristate ester potentiated ET-1-stimulated prostanoid secretion, whereas it inhibited IP3 production. Data indicate that ET-1 activates phospholipase A2 (PLA2) and PLC in HBCEC by different intracellular mechanisms. The subsequently induced secretion of vasoactive prostanoids by HBCEC may contribute both qualitatively and temporally to the vasoactive actions of ET-1.

摘要

血管活性肽内皮素-1(ET-1)与多种疾病的病理生理学有关。最近,我们发现人脑内皮细胞既能分泌又能表达与磷脂酶C(PLC)激活偶联的免疫反应性ET-1高亲和力ETA受体。本研究表明,ET-1可浓度依赖性地刺激源自人脑的毛细血管内皮细胞(HBCEC)中前列腺素[血栓素B2(TxB2)、前列腺素F2α(PGF2α)、6-酮前列腺素F1α(6-酮PGF1α)、前列腺素E2(PGE2)和前列腺素D2(PGD2)]的产生。血管收缩性前列腺素TxA2和PGF2α的增加在时间上先于血管舒张性前列腺素PGI2、PGE2和PGD2的增加,并且在与ET-1(10 nM)孵育15分钟后即可观察到。在孵育4-8小时之间观察到血管舒张性前列腺素的产生增加,而在添加ET-1后24小时,血管收缩性和血管舒张性前列腺素均恢复正常。ETA受体的特异性拮抗剂BQ123可抑制ET-1刺激的前列腺素和IP3的产生。地塞米松(50μM)也可抑制HBCEC中ET-1诱导的前列腺素分泌,新霉素(50μM)和维拉帕米(10μM)可使其分泌减少,但硝苯地平无此作用。佛波醇肉豆蔻酸酯可增强ET-1刺激的前列腺素分泌,而抑制IP3的产生。数据表明,ET-1通过不同的细胞内机制激活HBCEC中的磷脂酶A2(PLA2)和PLC。随后HBCEC诱导的血管活性前列腺素分泌可能在质量和时间上对ET-1的血管活性作用都有贡献。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验